Prophylactic measures used for the prevention of postoperative endophthalmitis after cataract surgery: A survey of routine practice in Yemen

Saudi Medical Journal

Volumn 31, Issue 3, 2010, Pages 293-298

  Bamashmus, Mahfouth A ^a   Al Akily, Saleh A ^a   Saleh, Mahmoud F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; DICLOFENAC; GENTAMICIN; NEOMYCIN; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TOBRAMYCIN;

ARTICLE; CATARACT EXTRACTION; ENDOPHTHALMITIS; EVIDENCE BASED MEDICINE; HUMAN; PHACOEMULSIFICATION; PREOPERATIVE TREATMENT; PROPHYLAXIS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CATARACT EXTRACTION; ENDOPHTHALMITIS; HUMANS; INTERVIEWS AS TOPIC; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; QUESTIONNAIRES; YEMEN;

EID: 77949760345     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (200-2004): incidence, clinical settings and visual acuity outcomes after treatment. Am J Ophthalmol 2005; 139: 983-987.
2. West ES, Behrens A, McDonnell PJ, Tielsch JM, Schein OD. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology 2005; 112: 1388-1394.
3. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology 2002; 109: 13-24.
4. Gordon-Bennett P, Karas A, Flanagan D, Stephenson C, Hingorani M. A survey of measures used for the prevention of postoperative endophthalmitis after cataract surgery in the United Kingdom. Eye (Lond) 2008; 22: 620-627.
5. Ferguson AW, Scott JA, McGavigan J, Elton RA, McLean J, Schmidt U, et al. Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study. Br J Ophthalmol 2003; 87: 163-167.
6. Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 2007; 33: 978-988.
7. Chang DF, Braga-Mele R, Mamalis N, Masket S, Miller KM, Nichamin LD, et al. Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. J Cataract Refract Surg 2007; 33: 1801-1805.
8. Bamashmus M, Al-Akily S, Haider T. Eye doctors' directory in Yemen. The Yemeni Ophthalmic Society, 2008-2009. Yemen: AlTawjih AlManewy; 2005.
9. Hammoudi DS, Abdolell M, Wong DT. Patterns of perioperative prophylaxis for cataract surgery in Canada. Can J Ophthalmol 2007; 42: 681-688.
10. Al-Akily S, Bamashmus M, Al-Barrag A. Cataract surgical rate in Yemen. Saudi Journal of Ophthalmology 2008; 22: 3-7.
11. Bamashmus M, Al-Akily S, Al-Barrag A. Human resources and infrastructure for eye care in Yemen: Current status. Middle East J Ophthalmology 2006; 13: 154-157.
12. Krause L, Bechrakis NE, Heimann H, Kildal D, Foerster MH. Incidence and outcome of endophthalmitis over a 13-year period. Can J Ophthalmol 2009; 44: 88-94.
13. Krikonis TS, Panagiotoglou TD, Tsika C, Alegakis A, Pallikaris IG, Tsilimbaris MK. Endophthalmitis after cataract extraction: incidence, treatment, and outcome in Crete, Greece, during period 2000-2008. Semin Ophthalmol 2009; 24: 234-238.
14. Leong JK, Shah R, McCluskey PJ, Benn RA, Taylor RF. Bacterial contamination of the anterior chamber during phacoemulsification cataract surgery. J Cataract Refract Surg 2002; 28: 826-833.
15. Miño de Kaspar H, Chang RT, Singh K, Egbert PR, Blumenkranz MS, Ta CN. Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Arch Ophthalmol 2005; 123: 161-165.
16. Miño de Kaspar H, Kreutzer TC, Aguirre-Romo I, Ta CN, Dudichum J, Bayrhof M, et al. A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora. Am J Ophthalmol 2008; 145: 136-142.
17. Ta CN, Singh G, Miño de Kaspar H. Prospective study demonstrating the efficacy of combined preoperative three-day application of antibiotics and povidone-iodine irrigation. Ann Ophthalmol (Skokie) 2007; 39: 313-317.
18. Halachimi-Eyal O, Lang Y, Keness Y, Miron D. Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac. J Cataract Refract Surg 2009; 35: 2109-2114.
19. Gupta M, McKee H, Stewart O. Perioperative prophylaxis for cataract surgery: survey of ophthalmologists in the north of England. J Cataract Refract Surg 2004; 30: 2021-2022.
20. Ang GS, Barras CW. Prophylaxis against infection in cataract surgery: a survey of routine practice. Eur J Ophthalmol 2006; 16: 394-400.
21. Thoms SS, Musch DC, Soong HK. Postoperative endophthalmitis associated with sutured versus unsutured clear corneal cataract incisions. Br J Ophthalmol 2007; 91: 728-730.
22. Yu-Wai-Man P, Morgan SJ, Hildreth AJ, Steel DH, Allen D. Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg 2008; 34: 447-451.
23. Mandal K, Hildreth A, Farrow M, Allen D. Investigation into postoperative endophthalmitis and lessons learned. J Cataract Refract Surg 2004; 30: 1960-1965.
24. Montan PG, Wejde G, Setterquist H, Rylander M, Zetterstrom C. Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg 2002; 28: 982-987.
25. Leaming DV. Practice styles and preferences of ASCRS members-2003 survey. J Cataract Refract Surg 2004; 30: 892-900.
26. Solomon R, Donnenfield ED, Perry HD, Snyder RW, Nedrud C, Stein J, et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5% and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 2005; 112: 466-469.
27. Jensen MK, Fiscella RG, Moshirfar M, Mooney B. Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. J Cataract Refract Surg 2008; 34: 1460-1467.
28. Miño de Kaspar H, Koss MJ, He L, Blumenkranz MS, Ta CN. Antibiotic susceptibility of preoperative normal conjunctival bacteria. Am J Ophthalmol 2005; 139: 730-733.
29. Arantes TE, Cavalcanti RF, Diniz MD, Severo MS, Lins Neto J, Castro CM. Conjunctival bacterial flora and antibiotic resistance pattern in patients undergoing cataract surgery. Arq Bras Oftalmol 2006; 69: 33-36.
30. Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn Jr HW. In vitro fluoroquinolone resistnace in staphylococcal endophthalmitis isolates. Arch Ophthalmol 2006; 124: 479-483.
31. Benz MS, Scott IU, Flynn HW Jr, Unonius N, Miller D. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol 2004; 137: 38-42.